XML 34 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Business Segments and Geographic Areas
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Business Segments and Geographic Areas Business Segments and Geographic Areas
    
We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources. Our product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and fees related to sales representation, promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. These product lines' net sales and primary geographic market where the products are sold, are as follows for the years ended December 31, 2023, 2022 and 2021:
 
2023
 Orthopedic SurgeryGeneral SurgeryTotal
Primary Geographic Markets
United States$199,568 $500,592 $700,160 
Europe, Middle East & Africa127,637 98,616 226,253 
Asia Pacific123,043 74,358 197,401 
Americas (excluding the United States)82,910 38,020 120,930 
Total sales from contracts with customers$533,158 $711,586 $1,244,744 
2022
 Orthopedic SurgeryGeneral SurgeryTotal
Primary Geographic Markets
United States$173,176 $405,777 $578,953 
Europe, Middle East & Africa113,649 84,288 197,937 
Asia Pacific103,353 59,124 162,477 
Americas (excluding the United States)71,350 34,755 106,105 
Total sales from contracts with customers$461,528 $583,944 $1,045,472 
2021
 Orthopedic SurgeryGeneral SurgeryTotal
Primary Geographic Markets
United States$158,553 $393,980 $552,533 
Europe, Middle East & Africa108,457 81,238 189,695 
Asia Pacific107,590 63,628 171,218 
Americas (excluding the United States)63,824 33,365 97,189 
Total sales from contracts with customers$438,424 $572,211 $1,010,635 

Sales are attributed to countries based on the location of the customer. There were no significant investments in long-lived assets located outside the United States at December 31, 2023 and 2022.  No single customer represented over 10% of our consolidated net sales for the years ended December 31, 2023, 2022 and 2021.